J&J to buy Intra-Cellular Therapies for $14.6 billion

Intra-Cellular Therapies

13/01/2025 11:32

Jan 13 (Reuters) - Johnson & Johnson  JNJ.N  said on
Monday it would buy drugmaker Intra-Cellular Therapies  ITCI.O 
for $14.6 billion, boosting its presence in the market for
neurological disorder treatments.
    
   

 (Reporting by Puyaan Singh and Bhanvi Satija in Bengaluru;
Editing by Shilpi Majumdar)
 ((Puyaan.Singh@thomsonreuters.com;))